Cathay Biotech Stock Cash And Equivalents
| 688065 Stock | 42.02 0.48 1.13% |
Cathay Biotech fundamentals help investors to digest information that contributes to Cathay Biotech's financial success or failures. It also enables traders to predict the movement of Cathay Stock. The fundamental analysis module provides a way to measure Cathay Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cathay Biotech stock.
Cathay | Cash And Equivalents |
Cathay Biotech Company Cash And Equivalents Analysis
Cathay Biotech's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
In accordance with the recently published financial statements, Cathay Biotech has 0.0 in Cash And Equivalents. This is 100.0% lower than that of the Chemicals sector and 100.0% lower than that of the Materials industry. The cash and equivalents for all China stocks is 100.0% higher than that of the company.
Cathay Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cathay Biotech's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cathay Biotech could also be used in its relative valuation, which is a method of valuing Cathay Biotech by comparing valuation metrics of similar companies.Cathay Biotech is currently under evaluation in cash and equivalents category among its peers.
Cathay Fundamentals
| Return On Equity | 0.026 | ||||
| Return On Asset | 0.0106 | ||||
| Profit Margin | 0.14 % | ||||
| Operating Margin | 0.20 % | ||||
| Current Valuation | 21.17 B | ||||
| Shares Outstanding | 583.38 M | ||||
| Shares Owned By Insiders | 61.34 % | ||||
| Shares Owned By Institutions | 11.09 % | ||||
| Price To Book | 2.15 X | ||||
| Price To Sales | 8.69 X | ||||
| Revenue | 2.11 B | ||||
| Gross Profit | 2.44 B | ||||
| EBITDA | 608.83 M | ||||
| Net Income | 366.52 M | ||||
| Total Debt | 1.53 B | ||||
| Book Value Per Share | 19.74 X | ||||
| Cash Flow From Operations | 569.45 M | ||||
| Earnings Per Share | 0.68 X | ||||
| Target Price | 69.35 | ||||
| Number Of Employees | 1.8 K | ||||
| Beta | 0.63 | ||||
| Market Capitalization | 24.51 B | ||||
| Total Asset | 18.83 B | ||||
| Retained Earnings | 2.07 B | ||||
| Working Capital | 4.16 B | ||||
| Annual Yield | 0 % | ||||
| Net Asset | 18.83 B | ||||
| Last Dividend Paid | 0.19 |
About Cathay Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cathay Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cathay Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cathay Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Cathay Stock
Cathay Biotech financial ratios help investors to determine whether Cathay Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cathay with respect to the benefits of owning Cathay Biotech security.